title: Hepatitis C virus infection and kidney transplantation: newer options and a brighter future ahead?
abstract: Recent studies including the current article by Sawinski et al. demonstrate that hepatitis C virus (HCV) infection is associated with worse outcomes in kidney transplant recipients with and without HIV infection. We comment on the significance of these findings in the context of newer options for the treatment of HCV infection that have improved efficacy and fewer side effects when administered in both kidney transplant candidates and recipients.
authors.affiliation: Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
authors.forename: David
authors.initials: D
authors.lastname: Del Bello
authors.affiliation: Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Ross
authors.affiliation: Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
authors.forename: Shirish S
authors.initials: SS
authors.lastname: Huprikar
mesh_terms: D005260:Female; D006084:Graft Rejection / Q000453:epidemiology*; D006085:Graft Survival; D006679:HIV Seropositivity / Q000150:complications*; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D016030:Kidney Transplantation / Q000706:statistics & numerical data*; D008297:Male